Join

Integration of Biomimicry and Nanotechnology for Significantly Improved Detection of Circulating Tumor Cells (CTCs)

February 1, 2018
Cite this

Abstract

Circulating tumor cells (CTCs) have received a great deal of scientific and clinical attention as a biomarker for diagnosis and prognosis of many types of cancer. Given their potential significance in clinics, a variety of detection methods, utilizing the recent advances in nanotechnology and microfluidics, have been introduced in an effort of achieving clinically significant detection of CTCs. However, effective detection and isolation of CTCs still remain a tremendous challenge due to their extreme rarity and phenotypic heterogeneity. Among many approaches that are currently under development, this review paper focuses on a unique, promising approach that takes advantages of naturally occurring processes achievable through application of nanotechnology to realize significant improvement in sensitivity and specificity of CTC capture. We provide an overview of successful outcome of this biomimetic CTC capture system in detection of tumor cells from in vitro, in vivo, and clinical pilot studies. We also emphasize the clinical impact of CTCs as biomarkers in cancer diagnosis and predictive prognosis, which provides a cost-effective, minimally invasive method that potentially replaces or supplements existing methods such as imaging technologies and solid tissue biopsy. In addition, their potential prognostic values as treatment guidelines and that ultimately help to realize personalized therapy are discussed.

Comparison between cancer cells and leukocytes with cell rolling and multivalent binding
Advanced Drug Delivery Reviews Vol. 125 journal cover
Advanced Drug Delivery Reviews, 2018.

Published

Advanced Drug Delivery Reviews
Advanced Drug Delivery Reviews Vol. 125 journal cover

Cited by

This article is cited by 7 publications

  1. Poellmann, M. J., Bu, J., Liu, S., Wang, A. Z., Seyedin, S. N., Chandrasekharan, C., Hong, H., Kim, Y., Caster, J. M., & Hong, S. (2023). Nanotechnology and machine learning enable circulating tumor cells as a reliable biomarker for radiotherapy responses of gastrointestinal cancer patients. Biosensors & bioelectronics, 226, 115117. https://doi.org/10.1016/j.bios.2023.115117
  2. Dong, J., Chen, J. F., Smalley, M., Zhao, M., Ke, Z., Zhu, Y., & Tseng, H. R. (2020). Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications. Advanced materials (Deerfield Beach, Fla.), 32(1), e1903663. https://doi.org/10.1002/adma.201903663
  3. Yang, C., Chen, F., Wang, S., & Xiong, B. (2019). Circulating Tumor Cells in Gastrointestinal Cancers: Current Status and Future Perspectives. Frontiers in oncology, 9, 1427. https://doi.org/10.3389/fonc.2019.01427
  4. Sun, B., Hagan, C. T., 4th, Caster, J., & Wang, A. Z. (2019). Nanotechnology in Radiation Oncology. Hematology/oncology clinics of North America, 33(6), 1071–1093. https://doi.org/10.1016/j.hoc.2019.08.002
  5. Myung, J. H., Cha, A., Tam, K. A., Poellmann, M., Borgeat, A., Sharifi, R., Molokie, R. E., Votta-Velis, G., & Hong, S. (2019). Dendrimer-Based Platform for Effective Capture of Tumor Cells after TGFβ1-Induced Epithelial-Mesenchymal Transition. Analytical chemistry, 91(13), 8374–8382. https://doi.org/10.1021/acs.analchem.9b01181